Patient-level variables, including behavioral factors and comorbidities, influence the degree of weight loss achieved with ...

Clinical guidelines recommend adding antiobesity medications to lifestyle interventions to enhance weight loss; however, their effects when combined with digitally supported diet and exercise programs ...

Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods. Weight-loss experts spoke with Fox News Digital about ...

User engagement in a digital weight-loss service enhanced the effectiveness of GLP-1 receptor agonists and the dual glucose-dependent insulinotropic polypeptide (GIP)-GLP-1 receptor agonists in adults ...

In a world chasing speed—fast food, fast fashion, fast tech—it’s no surprise that quick slimming is the latest obsession. But the demand for rapid weight loss has opened a controversial new chapter in ...

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

Analysis of a large unsubsidized digital weight-loss service reveals that consistent treatment adherence and active engagement, not access alone, are the key factors separating modest results from ...

New research finds GLP-1 users significantly reduced physical activity, with daily steps and exercise declining after ...

There are many apps designed to help people lose weight. The bad news is that it takes more than a cool app to do so. Weight loss is about sustainable behavior change and it requires emotional and ...